Business Context and Reporting Period
Connect Biopharma Holdings Limited, a foreign private issuer filing on Form 6-K, reported an event occurring on June 16, 2021. The company files annual reports on Form 20-F.
Material Corporate Change
- Jennifer Jin tendered her resignation as a director, effective June 16, 2021.
- The filing states that her resignation was not due to any disagreement with the company regarding its operations, policies, or practices.
Financial Information
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics.
Guidance, Outlook, and Risks
The filing provides no guidance, outlook, management commentary, contingencies, or unusual financial items.
Investor Verification Items
- Verify the effective date and circumstances of Ms. Jin’s board resignation.
- Assess any resulting changes to the company’s board composition, committee assignments, or governance.
- Refer to subsequent SEC filings for any replacement director appointment or related corporate developments.